Results for “”

Entry Author Date Location
Bio Roundup: Agile Approval, Coronavirus Collabs, Spruce’s $88M & More 02/21/20 National
SeaGen Adds Five Prime Therapeutics Antibodies in Licensing Deal 02/20/20 Seattle
Spruce Bio Raises $88M for Clinical Tests of Rare Endocrine Disease Drug 02/20/20 San Francisco
Teva Drug Fails to Beat Placebo in Pediatric Tourette Patient Trials 02/19/20 National
Five Prime, Bristol Pancreatic Cancer Drug Combo Fails Phase 2 Test 02/18/20 San Francisco
Imara Reveals IPO Plan as Sickle Cell Drug Advances in the Clinic 02/18/20 Boston
Bio Roundup: Goodbye Belviq, LogicBio on Hold, Revolution’s IPO & More 02/14/20 National
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks 02/13/20 National
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer 02/12/20 San Francisco
Two Big Pharma Alliances End in Nixed Deals. Here’s What Happened. 02/11/20 National
Eli Lilly, Roche Drugs Fail to Move Needle in Genetically Driven Alzheimer’s 02/10/20 National
Bio Roundup: POTUS on Prices, a16z’s Fund, Aimmune’s Approval & More 02/07/20 National
Sonoma Bio Launches With $40M to Take Cell Therapy Beyond Cancer 02/06/20 San Francisco
Coda Bio Acquires Drug Candidates to Pair With Engineered Receptors 02/06/20 San Francisco
Aimmune Gets $200M From Nestlé; Licenses Food Allergy Drug Candidate 02/05/20 San Francisco
Merck Charts an R&D-Focused Course Starting With a $6.5B Spinoff 02/05/20 New York
Titan Medical’s Cash Crunch Stalls Plans to Get Surgical Robot to FDA 02/04/20 National
Verily, Santen See Ophthalmology Opportunity Via New Joint Venture 02/04/20 San Francisco
$750M Fund Looks to Software Sector to Drive Future of Biotech 02/04/20 National
Passage Bio Plans IPO as Three Gene Therapies Approach the Clinic 02/03/20 New York
Aimmune Awarded First FDA Approval for a Peanut Allergy Therapy 01/31/20 San Francisco
Arcutis Bio Raises $159M in Upsized IPO to Test Skin Disease Drugs 01/31/20 San Diego
Bio Roundup: Mammoth Moves, Black Diamond’s Pop, Ohana’s Debut & More 01/31/20 National
BIO Report: More Work Needed to Improve Diversity at Biotech Firms 01/30/20 National
With $45M, Mammoth Bio Expects Big Things From Tiny CRISPR Cas14 01/30/20 San Francisco
Black Diamond’s Upsized IPO Raises $201M to Advance Its Cancer Drug R&D 01/30/20 Boston
Histogen, Timber Pharma Plan Reverse Mergers to Join Public Markets 01/28/20 San Diego
BioIntelliSense Debuts “Sticker” Sensor to Capture Patient Data Remotely 01/28/20 Boulder/Denver
Advanced Therapies Are Reshaping Biopharma R&D: KPMG Report 01/28/20 National
Life Sciences IPOs Target Collective Raise of More Than $600M This Week 01/27/20 National
Page 1 of 198 next page »